1. Pharmacokinetic and pharmacodynamic profile of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial. Issue 8 (6th May 2018) Authors: Laffel, L. M. B.; Tamborlane, W. V.; Yver, A.; Simons, G.; Wu, J.; Nock, V.; Hobson, D.; Hughan, K. S.; Kaspers, S.; Marquard, J. Journal: Diabetic medicine Issue: Volume 35:Issue 8(2018) Page Start: 1096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0650 Early help seeking or self-management: a quantitative assessment in the context of rheumatoid arthritis. (12th June 2018) Authors: Simons, G.; Belcher, J.; Kumar, K.; Falahee, M.; Mallen, C.D.; Stack, R.J.; Raza, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗